
|Articles|February 23, 2007
Oncolytics Biotech Appoints Vice President, IP
Author(s)BioPharm International Editors
Oncolytics Biotech (Calgary, Canada, www.oncolyticsbiotech.com) has appointed Mary Ann Dillahunty as VP, Intellectual Property.
Advertisement
Oncolytics Biotech (Calgary, Canada,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Green Chemistry’s Role in Advancing US Chemical Innovation
2
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
3
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
4
European Approval of Donidalorsen Expands RNA-Targeted Prevention Strategies for HAE
5




